Skip to main content

Table 2 Quality of life according to mean scales of WHQ at the end of the first trial year, EPHT Trial

From: The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial

Variable

Non-HT arms

HT arms

p-value*

p-value

 

Mean

(SE)

Mean

(SE)

  

Depressed mood

0.22

(0.01)

0.21

(0.01)

0.308

0.539

Somatic symptoms

0.40

(0.01)

0.39

(0.01)

0.212

0.282

Memory/concentration

0.42

(0.01)

0.41

(0.01)

0.447

0.490

Vasomotor symptoms

0.36

(0.01)

0.21

(0.01)

<0.0001

<0.0001

Anxiety/fear

0.27

(0.01)

0.27

(0.01)

0.519

0.642

Sexual behaviour

0.46

(0.02)

0.36

(0.02)

0.001

<0.001

Sleep problems

0.39

(0.01)

0.34

(0.01)

0.005

0.005

Menstrual symptoms

0.25

(0.01)

0.28

(0.01)

0.027

0.017

Attractiveness

0.53

(0.01)

0.53

(0.01)

0.811

0.791

  1. * Wilcoxon rank sum test.
  2. t-test.